Trial intelligence / Profile preview

Manipulating Chloride Homeostasis in Stable Heart Failure

NCT03440970Phase 1Completed

Sponsor
Yale University
Start
Jan 2019
Primary completion
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in heart failure (HF) comparing Lysine Chloride with Placebo (2 arms). Primary endpoints: Mean Change in Blood Volume at Day 7 and Mean Change in Plasma Volume at Day 7. Started Jan 2019; status: completed.

02

Drugs

lysine chloride
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT03440970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03440970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call